InsidersTradesSigma
세니젠 Stock: price and management transactions · South Korea · DART (FSS)
Follow the 세니젠 stock price and the full directors' dealings record of the company, a listed equity based in South Korea. Shares are listed on KR KR, under the oversight of DART (FSS). Operating in the Health Care sector, 세니젠 has recorded 24 reports. Market capitalisation: €14.2bn. The latest transaction was filed on 25 June 2026 (Other). Among the most active insiders: 박정웅. All data is accessible without an account.
24
Insider Decl.
0
Thresholds
·
3 ops.
Buy Volume
·
8 ops.
Sell Volume
22Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 25,061 of 25,484 companies
8.7
score / 100
Value6
Quality11
FCF yld-31%
Earn yld-41%
EV/EBITDA·
ROE-94%
Gross mgn20%
Net mgn-38%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 25 June 2026
Declarations24 total
24 of 24 declarations
About 세니젠
세니젠 is a healthcare and pharmaceutical company listed on the XKRX. It specializes in developing innovative solutions for disease treatment.